ERBB2 and breast cancer: For HoR + /HER2- T1bN0M0 and T1cN0M0 BC, adjuvant chemotherapy is recommended for grade II and grade III T1cN0M0 BC when no genetic signature test has been performed or when the 21-gene assay indicates a medium risk.